Medisynth Chemicals Pvt Ltd, a active private limited company, was established on 04 February 1983 in Mumbai, Maharashtra, India. Engaging in alternative & holistic medicine within the trade sector, it holds CIN: U24110MH1983PTC029252. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Nihar Jayant Vaknalli (Director), Jayant Manjunath Vaknalli (Director), Sunila Sharad Vaknalli (Director). Past directors included Nihar Jayant Vaknalli, Ashutosh Arvind Nair, Jayant Manjunath Vaknalli. It holds ₹9.60 Cr open charges and ₹7.23 Cr settled loans. Its latest AGM occurred on 19 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4, Arif Mansion, 1St Floor, Irla Society Road, Vile Parle West,, Mumbai, Maharashtra, 400056.
U24110MH1983PTC029252
029252
04 February 1983
₹2.50 M
₹2.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medisynth Chemicals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nihar Jayant Vaknalli | Director | 01 Mar 2014 | Current |
| Jayant Manjunath Vaknalli | Director | 30 Aug 2018 | Current |
| Sunila Sharad Vaknalli | Director | 30 Aug 2018 | Current |
| Riti Sharad Vaknalli | Director | 04 Nov 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 29 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 26 Dec 2008 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 20 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medisynth Chemicals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 14.25% increase. The company also saw a substantial improvement in profitability, with a 83.29% increase in profit. The company's net worth Soared by an impressive increase of 24.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Medisynth Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹96,000,000.00
₹72,326,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2014 | Axis Bank Limited | ₹4.80 Cr | Open |
| 29 Nov 2012 | Axis Bank Limited | ₹4.80 Cr | Open |
| 05 Dec 2014 | Aditya Birla Finance Limited | ₹1.75 Cr | Satisfied |
| 28 Mar 2008 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹6.72 M | Satisfied |
| 30 Sep 2000 | The Shamarao Vithal Co - Op. Bank Ltd. | ₹6.30 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medisynth Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medisynth Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisynth Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Medisynth Chemicals Pvt Ltd last Annual general meeting of members was held on 19 Sep 2025 as per latest MCA records. was documented.
Progress on Medisynth Chemicals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
A charge with Axis Bank Limited of Rs. 48.00 M registered on 05 Jun 2014 with Charge ID 10503389 was modified on 27 Feb 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited of Rs. 48.00 M registered on 29 Nov 2012 with Charge ID 10388833 was modified on 01 Sep 2023. was completed.
The activity A charge registered on 27 Jan 1984 via Charge ID 90165823 with The Saraswat Co - Op. Bank Ltd. was fully satisfied on 08 Feb 2021. was completed.
The activity Riti Sharad Vaknalli was appointed as a Director was appointed as a Director on 04 Nov 2019 & has been associated with this company since 6 years 30 days . was completed.
The CIN of Medisynth Chemicals Pvt Ltd is U24110MH1983PTC029252.
Medisynth Chemicals Pvt Ltd is headquartered at 4, Arif Mansion, 1St Floor, Irla Society Road, Vile Parle West,, Mumbai, Maharashtra, 400056.
Medisynth Chemicals Pvt Ltd was incorporated on 04 February 1983.
The current directors of Medisynth Chemicals Pvt Ltd are
The primary industry of Medisynth Chemicals Pvt Ltd is Trade.
Medisynth Chemicals Pvt Ltd is unlisted.
The authorized capital of Medisynth Chemicals Pvt Ltd is ₹2.50 M, and the paid-up capital is ₹2.00 M.
The compliance status of Medisynth Chemicals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX